Paul McCormac

Insider Reports History

Entity
Individual
Location
C/O Lexeo Therapeutics, Inc., 345 Park Avenue South, 6 Th Floor, New York, NY
Signature
/s/ Jenny Robertson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul McCormac:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Lexeo Therapeutics, Inc. Chief Technical Officer Common Stock 17.3K $229K $13.22 Nov 7, 2023 Direct
Lexeo Therapeutics, Inc. Chief Technical Officer Series B convertible preferred stock 0 Nov 7, 2023 Direct

Insider Reports Filed by Paul McCormac

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LXEO Lexeo Therapeutics, Inc. Nov 7, 2023 2 $0 4 Nov 9, 2023 Chief Technical Officer
LXEO Lexeo Therapeutics, Inc. Nov 2, 2023 0 $0 3 Nov 2, 2023 Chief Technical Officer